CME Corner

Active Programs

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation Online Presentation

Individualized Management of Pediatric Allergic Asthma

An evolving understanding of pediatric allergic asthma’s complex immunopathology is contributing to new treatment paradigms. This activity will examine the impact of asthma phenotypes and endotypes on treatment selection. ...

  • Online Presentation Online Presentation

Diagnosis of Pediatric Allergic Asthma

In the United States, 8.6% of children (approximately 6.3 million) have asthma, and ~80% of these children have allergic asthma. This activity will review the epidemiology of pediatric allergic asthma and outline strategies for diagnosis, assessment of severity, and initial therapy. ...

  • Online Presentation Online Presentation

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on QuantiaMD

Expired Programs

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter

Progress Against Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia, and its diagnosis and management remain a challenge in clinical practice. An expanding body of research on the pathogenesis of IPF, however, is leading to the identification of new therapeutic targets, and best practices are evolving with the emergence of new data and new therapies. This activity, which featu ...

  • Video Roundtable
Main Menu